Skip to main content

Advertisement

SpringerLink
Log in

Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome

  • Images in Nephrology
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Hass M, Weisstuch J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129–36.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Izzedine H, Escudier B, Lhomme C, Pautier P, Rouvier P, Guetin V, et al. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF). Medicine. 2014;93:333–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89:1221–30.

    Article  PubMed  CAS  Google Scholar 

  4. Wu S, Kim C, Baer L, Zhu X. Bevacizumab increases risk for severe proteinuria in cancer patients. J Am Soc Nephrol. 2010;21:1381–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Yahata M, Nakaya I, Sakuma T, Sato H, Aoki S, Soma J. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature. BMC Res Notes. 2013;6:450.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Teine Keijinkai Medical Center, Sapporo, Hokkaido, Japan

    Yoshinosuke Shimamura, Takuto Maeda & Hideki Takizawa

Authors
  1. Yoshinosuke Shimamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takuto Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideki Takizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshinosuke Shimamura.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number: 2017-120) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimamura, Y., Maeda, T. & Takizawa, H. Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome. Clin Exp Nephrol 23, 142–143 (2019). https://doi.org/10.1007/s10157-018-1596-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-018-1596-9

Keywords

Search

Navigation